149
Views
29
CrossRef citations to date
0
Altmetric
Research Article

A comparative trial of two retinoids commonly used in the treatment of acne vulgaris

Pages 149-157 | Published online: 12 Jul 2009

  • Leyden JJ. Therapy for acne vulgaris. N Engl J Med (1997) 336:1156-62.
  • Kligman AM, Fulton JK, Plewig G, Topical vitamin A acid in acne vulgaris. Arch Derma toi ( 1969) 99: 469-76.
  • Peachey RDG, Connor BL, Topical retinoic acid in the treatment of acne vulgaris. Br J Dermatol (1971) 85: 462-6.
  • Juhlin L, Topical vitamin A acid in acne vulgaris. Acta Derm Venereol Suppl(Stockh) (1975) 74: 133-4.
  • Lucky AW, Cullen SL Jarratt MT, Quigley JW, Comparative efficacy and safety of two 0.025% tretinoin gels: results from a multicenter, double-blind, parallel study. J Am Acad Dermatol (1998) 38:S17-23.
  • Kmbil K, Nacht S, The MicrospongeR Delivery System (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J Microencapsul (1996) 13: 575-88.
  • Grove GL, Zerweck CR, Nacht S, Leyden Jl, The effect of vehicle composition on the subjective and objective irritancy potential of retinoic acid formulations. Poster presentation at the American Academy of Dermatology meeting: March 1997: San Francisco, CA.
  • Shalita A, Weiss JS, Chalker K, et al, A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol (1996) 34: 482-5.
  • Martin B, Meunier C, Montels D, Watts O, Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. Br J Dermatol (1998) 139(suppl 52): 8-11.
  • Verschoore M, Langner A, Wolska H, et al, Ffficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris. Br J Dermatol (1991) 124: 368-71.
  • Alirezai M, Meynadier J, Jablonska S, et al, Ftude comparative de l'efficacité et de la tolérance de gels d'adapalène a 0,1 et 0.03 p. 100 et d'un gel de trétinoïne a 0,025 p. 100 dans le traitement de l'acné. Aim Derma toi Vmcreol (1996) 123: 165-70.
  • Cunliffe Wf, Caputo R, Dreno B, et al, Efficacy and safety comparison of adapalene (CD271) gel and tretinoin gel in the topical treatment of acne vulgaris. A European multicentre trial. J Dermatol Treat (1997) 8: 173-8.
  • Ellis CN, Millikan LE, Smith EB, et al, Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris. Br J Dermatol (1998) 139 (suppl 52): 41-7.
  • Grosshans E, Marks R, Mascaro JM, et al, Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br J Dermatol (1998) 139 (suppl 52): 26-31
  • Piérard-Franchimont C, Henry E, Eraiture AL, et al, Splitface clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne. Dermatology (1999)198:218-22.
  • Savin RC, Berger RS, Split-face comparison of tretinoin cream 0.025% and adapalene gel 0.1% in the treatment of acne vulgaris. Cosmetic Dermatol (1999) 12: Feb: 29-32.
  • Lavker RM, Leyden JJ, Thorne EG, An ultrastructural study of the effects of topical tretinoin on microcomedones. Clin Ther(1992) 14:773-80.
  • Bernerd E, Ortonne J-P, Bouclier M, et al, The rhino mouse model: the effects of topically applied all-trans retinoic acid and CD271 on the tine structure of the epidermis and utricle wall of pseudocomedones. Arch Dermatol Res ( 1991) 283: 100-7.
  • Bouclier M, Chatelus A, Eerracin J, et al, Quantification of epidermal histological changes induced by topical retinoids and CD271 in the rhino mouse model using a standardized image analysis technique. Skin Pharmacol ( 1991 ) 4: 65-73.
  • Griffiths CEM, Elder JT, Bernard BA, et al, Comparison of CD271 (adapalene) and all-fraiis retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression.J Invest Dermatol ( 1993) 101: 325-8.
  • Studler R, Müller R, Detmar M, Orfanos CE. Retinoids and keratinocyte differentiation in vitro. Dermatologica(1987) 175 (suppl 1): 45-55.
  • Gollnick H, Schramm M, Topical drug treatment in acne. Dermatolgy(1998) 196: 119-25.
  • Hensby C, Cavey D, Bouclier M, et al, The in vivo and in vitro anti-inflammatory activity of CD271: a new retinoidlike modulator of cell differentiation. Agents Actions (1990) 29: 56-8.
  • Fuchs E, Green H, Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell (1981) 25:617-25.
  • Magnaldo T, Bernerd F, Asselineau D, Darmon M, Expression of loricrin is negatively controlled by retinoic acid in human epidermis reconstructed in vitro. Differentiation (1992)49: 39-46.
  • Asselineau D, Dale BA, Bernard BA, Filaggrin production by cultured human epidermal keratinocytes and its regulation by retinoic acid. Differntiation(1990) 45: 221-9.
  • Hohl D, Lichti U, Breitkreutz D, et al, Transcription of the human loricrin gene in vitro is induced by calcium and cell density and suppressed by retinoic acid. J Invest Deermatol (1991)96:414-18.
  • Griffiths CEM, Rosenthal DS, Reddy AP, et al, Short-termretinoic acid treatment increases in vivo, but decreases in vitro, epidermal transglutaminase-K enzyme activity and immunoreactivity.J Invest Dermotol (1992) 99: 283- 8.
  • Asselineau D, Cavey M-T, Shroot B, Darmon M, Control of epidermal differentiation by a retinoid analogue unable to bind to cytosolic retinoic acid-binding proteins (CRABP). J Invest Dermatol (1992) 98:128-34.
  • Fisher GJ. Voorhees JJ. Molecular mechanisms of retinoid actions In skin. FASEB J(1996) 10:1002-13.
  • Michel S, Jomard A. Démarchez M. Pharmacology of adapalene. Br J Dermatol(1998) 1139(suppl 52): 3-7.
  • Rosenthal DS. Griffiths CEM, Yuspa SH. et al. Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin. involucrin. filaggrin, and keratins 6 and 13 but not keratins 1. K). and 14. / Invest Derma toi (1992) 98: 343-50.
  • Fisher GJ. Esmann J. Griffiths CEM, et al. Cellular, immunologie and biochemical characterization of topical retinoic acid-treated human skin. J Invest Derma toi (1991) 96: 699-707.
  • Weiss JS. Ellis CN. Headington JT. et al. Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study. JAMA ( 1955) 259: 527-32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.